Patent ID: 7138542
Filing Date: 2006-11-21
Classification: A61K,A61P

Abstract:
1. A method of treating tinnitus in a mammal suffering therefrom, comprising administering a therapeutically effective amount of an alpha2delta ligand selected from 3-Aminomethyl-5-methyl-octanoic acid; (3S,5R)-3-Aminomethyl-5-methyl-octanoic acid; (1α,3β,5α)(3-Aminomethyl-bicyclo[3.2.0]hept-3-yl)-acetic acid; (1α,3α,5α)(3-Aminomethyl-bicyclo[3.2.0.]hept-3-yl)-acetic acid hydrochloride; and (S,S)-(1-aminomethyl-3,4-dimethyl-cyclopentyl)-acetic acid or pharmaceutically acceptable salts thereof.